SYRS
Syros Pharmaceuticals, Inc. · Healthcare
Director and 10% owner Robert Nelsen bought $5.0M of Syros Pharmaceuticals, Inc.
Bought$5,000,000
$12.50Price
400,000Shares
+9%Stake
What SYRS did for a copier
Prices for SYRS after this filing aren't in yet.
Robert Nelsen's record
3 other buys with 3 months of prices since 2019: on average +5.5% against the S&P 500, and 2 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Jul 6. Filed Wed, Jul 6, 9:22 PM ET, after the close. Not investment advice.